Cyclosomatostatin

Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells[1].

Product Specifications

CAS Number

[84211-54-1]

UNSPSC

12352209

Target

Somatostatin Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cyclosomatostatin.html

Purity

99.76

Solubility

H2O : 10 mg/mL (ultrasonic)

Smiles

O=C(N[C@@](C(N[C@@]1([H])[C@@H](C)OCC2=CC=CC=C2)=O)([H])CCCCN)[C@H](NC([C@@H](NC(CCCCCCNC1=O)=O)CC3=CC=CC=C3)=O)CC4=CNC5=C4C=CC=C5

Molecular Formula

C44H57N7O6

Molecular Weight

779.97

References & Citations

[1]Shirin R Modarai, et al. Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells. BMC Cancer. 2016 Dec 7;16 (1) :941.